Cargando…

Comment on: Consolidation treatment for high risk solid tumors in children with myeloablative chemotherapy and autologous hematopoietic progenitor stem cell transplantation

Detalles Bibliográficos
Autor principal:	Kletzel, Morris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Hematologia e Hemoterapia 2013
Materias:	Scientific Comments
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832307/ https://www.ncbi.nlm.nih.gov/pubmed/24255610 http://dx.doi.org/10.5581/1516-8484.20130104

Ejemplares similares

Consolidation treatment for high risk solid tumors in children with myeloablative chemotherapy and autologous hematopoietic progenitor stem cell transplantation
por: Vargas, Alberto Olaya, et al.
Publicado: (2013)

Peripheral hematopoietic progenitor cell mobilization for autologous transplantation in hematologic malignancies
por: Marques Jr, José Francisco Comenalli
Publicado: (2011)

Comment on: Bacteremia in pediatric patients with hematopoietic stem transplantation()
por: Macedo, Antonio Vaz de
Publicado: (2020)

Comment on: clinical impact of systematic nutritional care in adults submitted to allogeneic hematopoietic stem cell transplantation
por: Daudt, Liane Esteves
Publicado: (2012)

Comment on “Nutritional status of patients submitted to transplantation of allogeneic hematopoietic stem cells: a retrospective study”()
por: Schmidt, Erin M., et al.
Publicado: (2014)

Comment on “Outcomes of autologous transplantation for multiple myeloma according to different induction regimens”
por: de la Rubia, Javier
Publicado: (2014)

Conditioning regimen using busulfan plus melphalan in hematopoietic stem cell transplantation: can this conditioning regimen be used in autologous or allogeneic transplantation for acute leukemia?
por: Lemoli, Roberto M., et al.
Publicado: (2011)

Neutropenic diets in hematopoietic stem cell transplantation
por: Albertini, Silvia Maria
Publicado: (2012)

Hematopoietic stem cell transplantation for Hodgkin's disease
por: Patah, Poliana, et al.
Publicado: (2011)

Body composition assessment in hematopoietic stem cell transplantation()
por: Ueda, Masumi
Publicado: (2017)

Hematopoietic stem cell mobilization for autologous transplantation in multiple myeloma patients previously exposed to cyclophosphamide, thalidomide, and dexamethasone: is granulocyte-colony stimulating factor alone enough?()
por: Vigorito, Afonso Celso
Publicado: (2016)

Myeloablative Chemotherapy with Autologous Stem Cell Transplant for Desmoplastic Small Round Cell Tumor
por: Forlenza, Christopher J., et al.
Publicado: (2015)

Upfront consolidation treatment with (131)I‐mIbG followed by myeloablative chemotherapy and hematopoietic stem cell transplantation in high‐risk neuroblastoma
por: Feng, Jianhua, et al.
Publicado: (2020)

Diarrhea after autologous stem cell transplantation in low-middle income countries: is Clostridium difficile the most prevalent infectious etiology?()
por: Cunha, Renato
Publicado: (2018)

Importance of functional evaluation after hematopoietic cell transplantation
por: Flowers, Mary Evelyn Dantas
Publicado: (2012)

Understanding population-wide haplotype frequencies of human leukocyte antigen (HLA) alleles in linkage disequilibrium is important for hematopoietic stem cell transplantation()
por: Otegbeye, Folashade
Publicado: (2017)

A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations
por: Atilla, Erden, et al.
Publicado: (2017)

Evaluation of respiratory conditions in early phase of hematopoietic stem celltransplantation
por: de Carvalho, Celso Ricardo Fernandes
Publicado: (2012)

Treating Relapsed/Refractory Acute Myeloid Leukemia with Chidamide, Fludarabine, Cytarabine and Granulocyte-Colony Stimulating Factor with Subsequent Bridging to Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation
por: Yao, Wen, et al.
Publicado: (2022)

Clostridium difficile infection is a frequent but well-controlled event after hematopoietic cell transplantation()
por: Caimi, Paolo Fabrizio
Publicado: (2015)

Comparison of post-remission strategies in acute myeloid leukemia: Autologous hematopoietic stem cell transplantation versus consolidation chemotherapy
por: Yegin, Zeynep Arzu, et al.
Publicado: (2020)

Low toxicity and favorable clinical and quality of life impact after non-myeloablative autologous hematopoietic stem cell transplant in Crohn’s disease
por: Ruiz, Milton Artur, et al.
Publicado: (2017)

Special features of quantification of CD8(+)CD38(+) T-cells by flow cytometry does not represent a good biomarker to monitor the reactivation of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation
por: Martins Filho, Olindo Assis
Publicado: (2011)

Autologous Hematopoietic Recovery after Unrelated Umbilical Cord Blood Transplantation with Myeloablative Conditioning for Acute Myelogenous Leukemia
por: Gomyo, Ayumi, et al.
Publicado: (2020)

Supplementation with Oral Vitamin C Prior to and during Myeloablative Chemotherapy and Autologous Haematopoietic Stem Cell Transplantation: A Pilot Study
por: Carr, Anitra C., et al.
Publicado: (2022)

Myeloablative treatment supported by autologous stem cell infusion with neuroblastoma.
por: Ryu, Kyung Ha, et al.
Publicado: (2003)

Patients Undergoing Myeloablative Chemotherapy and Hematopoietic Stem Cell Transplantation Exhibit Depleted Vitamin C Status in Association with Febrile Neutropenia
por: Carr, Anitra C., et al.
Publicado: (2020)

Comments on renal abnormalities of sickle cell disease
por: Abbud-Filho, Mario
Publicado: (2013)

Radiation Therapy for Young Children Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant for Primary Brain Tumors
por: Milgrom, Sarah A., et al.
Publicado: (2022)

Comment on sickle cell disease and left ventricular hypertrophy()
por: Verissimo, Monica Pinheiro de Almeida
Publicado: (2015)

Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery
por: Green, Michael M. B., et al.
Publicado: (2016)

Comment on “Influence of βS-globin haplotypes and hydroxyurea on tumor necrosis factor-alpha levels in sickle cell anemia”
por: de Souza Torres, Lidiane
Publicado: (2014)

Comment on "The influence of hydroxyurea on oxidative stress in sickle cell anemia"
por: van Beers, Eduard Johannes, et al.
Publicado: (2012)

Comment on: oxidative stress and antioxidant status in beta-thalassemia heterozygotes
por: Shekhar, Hossain Uddin
Publicado: (2013)

Scientific comment on tumor suppressor p53 protein expression: prognostic significance in patients with low-risk myelodysplastic syndrome
por: Velloso, Elvira Deolinda Rodrigues Pereira
Publicado: (2014)

Comment on: the relationship between splenomegaly and hematologic findings in patients with hepatosplenic schistosomiasis
por: Montenegro, Silvia Maria Lucena
Publicado: (2013)

Comment on: Relationship between lipid and hematological profiles and adiposity in obese adolescents
por: Guerra, Ricardo Luís Fernandes
Publicado: (2013)

Comment on: Relationship between splenomegaly and hematologic findings in patients with hepatosplenic schistosomiasis
por: Kaiser Junior, Roberto Luiz
Publicado: (2013)

Scientific comment on the theme of palliative care in pediatric hematological oncology patients()
por: Jankovic, Momcilo
Publicado: (2014)

Allogeneic hematopoietic stem cell transplantation in congenital hemoglobinopathies with myeloablative conditioning and rabbit anti-thymocyte globulin
por: Park, Bo-Kyoung, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3ajame35gv24ddthkncjsbd47b